Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,990 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial.
Jabbour E, Short NJ, Senapati J, Jain N, Huang X, Daver N, DiNardo CD, Pemmaraju N, Wierda W, Garcia-Manero G, Montalban Bravo G, Sasaki K, Kadia TM, Khoury J, Wang SA, Haddad FG, Jacob J, Garris R, Ravandi F, Kantarjian HM. Jabbour E, et al. Among authors: kantarjian hm. Lancet Haematol. 2023 Jun;10(6):e433-e444. doi: 10.1016/S2352-3026(23)00073-X. Epub 2023 May 12. Lancet Haematol. 2023. PMID: 37187201 Clinical Trial.
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study.
Ravandi F, Kantarjian H, Cohen A, Davis M, O'Brien S, Anderlini P, Andersson B, Claxton D, Donato M, Gajewski J, Khouri I, Korbling M, Ueno N, deVos D, Champlin R, Giralt S. Ravandi F, et al. Bone Marrow Transplant. 2001 Jun;27(12):1221-5. doi: 10.1038/sj.bmt.1703028. Bone Marrow Transplant. 2001. PMID: 11548839 Clinical Trial.
Cellular signalling pathways: new targets in leukaemia therapy.
Ravandi F, Talpaz M, Kantarjian H, Estrov Z. Ravandi F, et al. Br J Haematol. 2002 Jan;116(1):57-77. doi: 10.1046/j.1365-2141.2002.03236.x. Br J Haematol. 2002. PMID: 11841398 Free article. Review. No abstract available.
Current therapy of chronic myelogenous leukemia.
Garcia-Manero G, Talpaz M, Kantarjian HM. Garcia-Manero G, et al. Among authors: kantarjian hm. Intern Med. 2002 Apr;41(4):254-64. doi: 10.2169/internalmedicine.41.254. Intern Med. 2002. PMID: 11993784 Free article. Review.
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course.
Verstovsek S, Lin H, Kantarjian H, Saglio G, De Micheli D, Pane F, Garcia-Manero G, Intrieri M, Rotoli B, Salvatore F, Guo JQ, Talpaz M, Specchia G, Pizzolo G, Liberati AM, Cortes J, Quackenbush RC, Arlinghaus RB. Verstovsek S, et al. Cancer. 2002 May 1;94(9):2416-25. doi: 10.1002/cncr.10490. Cancer. 2002. PMID: 12015767 Free article.
1,990 results